Transgenic 4-1BBL-engineered vaccine stimulates potent Gag-specific therapeutic and long-term immunity via increased priming of CD44(+)CD62L(high) IL-7R(+) CTLs with up- and downregulation of anti- and pro-apoptosis genes (Q35833636)
Jump to navigation
Jump to search
scientific article published on 8 September 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Transgenic 4-1BBL-engineered vaccine stimulates potent Gag-specific therapeutic and long-term immunity via increased priming of CD44(+)CD62L(high) IL-7R(+) CTLs with up- and downregulation of anti- and pro-apoptosis genes |
scientific article published on 8 September 2014 |
Statements
1 reference
Transgenic 4-1BBL-engineered vaccine stimulates potent Gag-specific therapeutic and long-term immunity via increased priming of CD44(+)CD62L(high) IL-7R(+) CTLs with up- and downregulation of anti- and pro-apoptosis genes (English)
1 reference
Rong Wang
1 reference
Andrew Freywald
1 reference
Yue Chen
1 reference
Jianqing Xu
1 reference
Xin Tan
1 reference
Jim Xiang
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference